Earnings Labs
Allogene Therapeutics, Inc. logo

Allogene Therapeutics, Inc. (ALLO)

NASDAQ·Healthcare·Biotechnology

$2.20

-2.05%

Mkt Cap $563.34M

Analyst Ratings

Buy

6

Hold

1

Sell

0

Price Target (10 analysts)

$29.00

Range $7.00$55.00

Implied Upside

+1215.9%

Consensus $29.00 vs current $2.20